Skip to content

Psilocybin: all studies

Page 227 of 439: studies 2,261 to 2,270 of 4,389, newest first. Back to the psilocybin overview

Research

Psychedelics for treatment resistant depression: are they game changers?

Expert Opinion on Pharmacotherapy November 10, 2023 Michail Kalfas, Rosie H Taylor, Dimosthenis Tsapekos et al. 28 citations

Psychedelic therapy has created a paradigm shift in the treatment of TRD, as it can maximize therapeutic benefits and minimize potential risks. Psilocybin holds promise as a potential game-changer in the treatment of TRD, with initial evidence suggesting a rapid antidepressant effect sustained for some responders for at least 3 months. Nevertheless, further adequately powered, double-blind,...

The psychedelic effects of cannabis: A review of the literature

Journal of Psychopharmacology November 10, 2023 David Wolinsky, Frederick Streeter Barrett, Ryan Vandrey 16 citations

Cannabis and classic psychedelics are controlled substances with emerging evidence of efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been regarded as having psychedelic effects in contemporary literature, despite many examples of historical use along with classic psychedelics to attain altered states of consciousness. Research into the “psychedelic”...

The entropic heart: Tracking the psychedelic state via heart rate dynamics

bioRxiv (Cold Spring Harbor Laboratory) November 9, 2023 Fernando E. Rosas, Pedro A. M. Mediano, Christopher Timmermann et al. 14 citations preprint

A growing body of work shows that autonomic signals provide a privileged evidence-stream to capture various aspects of subjective and neural states. This work investigates the potential for autonomic markers to track the effects of psychedelics — potent psychoactive drugs with important scientific and clinical value. For this purpose, we introduce a novel Bayesian framework to estimate the...

DOI: 10.1101/2023.11.07.566008 (opens in new tab) Full text (opens in new tab) Psilocybin Heart rate variability Artificial intelligence Hallucinogen +1

The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review

Journal of Sociology, Psychology & Religious Studies November 6, 2023 Sarah Naher, Sarah Naher 1 citation

Mental illnesses pose social, economic, and health burdens worldwide. The increasing health burden and mental diseases pose the need for investigating other potential medications. The present review focuses on psychedelic medications. The Patient/Participant, Intervention, Outcomes, and Studies ([PICOS) protocol and the Preferred Reporting Items for Systematic Reviews (PRISMA) checklist guided...

Mindfulness meditation and psychedelics: potential synergies and commonalities

Pharmacological Reports November 6, 2023 Paweł Holas, Justyna Kamińska 39 citations

Abstract There has been increasing scientific and clinical interest in studying psychedelic and meditation-based interventions in recent years, both in the context of improving mental health and as tools for understanding the mind. Several authors suggest neurophysiological and phenomenological parallels and overlaps between psychedelic and meditative states and suggest synergistic effects of...

DOI: 10.1007/s43440-023-00551-8 (opens in new tab) Full text (opens in new tab) Psilocybin Decentering Mindfulness-based interventions Mystical experiences +7

Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland

Læknablaðið November 3, 2023 Ragnar Olafsson, Karól Kvaran, Kristín Ketilsdóttir et al. 5 citations

INTRODUCTION: Interest in the use of psychedelics has increased following reports of their possible therapeutic potential. However, little is known about the knowledge of and attitudes towards the substances among health care professional who provide treatment for mental disorders in Iceland. An online survey was therefore conducted among members of the Icelandic associations of psychiatrists,...

Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports

Journal of Psychoactive Drugs November 3, 2023 Marija Franka Žuljević, Antonija Mijatović, Stjepan Ljudevit Marušić et al. 6 citations

Analyzing online retrospective experience reports of psychedelic use can provide valuable insight into their acute subjective effects. Such reports are unexplored in relation to mystical states, which are thought to be a therapeutic mechanism within psychedelic-assisted psychotherapy. We created a set of words that, when encountered in an experience report, indicate the occurrence of mystical...

DOI: 10.1080/02791072.2023.2274382 (opens in new tab) Psilocybin Experience reports Language analysis Mystical states +8

Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms

Addiction November 2, 2023 Celia J. A. Morgan 1 citation

Given the shifting public perception of psilocybin and associated legal changes, the increase in use observed by Keyes and Patrick is not surprising. The conclusion that this is a rising health concern is not justified by the data, particularly as in this sample non-lysergic acid diethylamide hallucinogen use seems to have increased in a white, educated, relatively higher socio-economic status...

Cultivation, chemistry, and genome of Psilocybe zapotecorum

bioRxiv (Cold Spring Harbor Laboratory) November 2, 2023 Jordan Taylor Jacobs, Alan Rockefeller, Harte Singer et al. 4 citations preprint

Abstract Psilocybe zapotecorum is a strongly blue-bruising psilocybin mushroom used by indigenous groups in southeastern Mexico and beyond. While this species has a rich history of ceremonial use, research into its chemistry and genetics have been limited. Herein, we detail mushroom morphology and report on cultivation parameters, chemical profile, and the full genome sequence of P. zapotecorum...

Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.

Neuroscience & Biobehavioral Reviews November 1, 2023 Sophia Linguiti, Jacob W Vogel, Valerie J Sydnor et al. 15 citations

Functional magnetic resonance imaging (fMRI) is increasingly used to non-invasively study the acute impact of psychedelics on the human brain. While fMRI is a promising tool for measuring brain function in response to psychedelics, it also has known methodological challenges. We conducted a systematic review of fMRI studies examining acute responses to experimentally administered psychedelics...